featured
Effects of Dapagliflozin on Energy Metabolism in Patients With Type 2 Diabetes
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Diabetes Care
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Effects of the SGLT2 Inhibitor Dapagliflozin on Energy Metabolism in Patients With Type 2 Diabetes: A Randomized, Double-Blind Crossover Trial
Diabetes Care 2021 Apr 15;[EPub Ahead of Print], YJM Op den Kamp, M de Ligt, B Dautzenberg, E Kornips, R Esterline, MKC Hesselink, J Hoeks, VB Schrauwen-Hinderling, B Havekes, J Oscarsson, E Phielix, P SchrauwenFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.